GlassScriptPhysician profile
Valentine Enemuo
NPI 1174782395
$1,379.34
in general payments reported to CMS, 2019-2025
17 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $34.99 · 2021: $472 · 2022: $227 · 2023: $120 · 2024: $155 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $241.08 | 2021-2022 | |
| Travere Therapeutics, INC. | $225.29 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $160.08 | 2019-2025 | Bylvay |
| Genzyme Corporation | $146.48 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $119.62 | 2023 | Breztri |
| Phadia US INC. | $90.60 | 2021 | |
| Mirum Pharmaceuticals, INC. | $85.66 | 2024 | Livmarli |
| Celgene Corporation | $55.00 | 2019 | |
| Novo Nordisk INC | $47.77 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.78 | 2024 | Gattex |
| Jazz Pharmaceuticals INC. | $36.55 | 2019 | |
| Abbvie INC. | $26.99 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $25.33 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.01 | 2019 | |
| Tandem Diabetes Care, INC. | $18.81 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $17.94 | 2021 | |
| Qol Medical, LLC | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valentine Enemuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.